The U.S. Food and Drug Administration (FDA) has granted clearance to a new AI-driven wearable device that monitors heart rhythms and predicts cardiovascular risks with 92% accuracy. Developed by CardioTech Inc., the device uses machine learning to analyze real-time biometric data and alerts users of potential heart conditions before symptoms appear. Experts believe this innovation could reduce emergency hospitalizations by 30% in high-risk populations